Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...